INSULIN GLULISINE (Apidra®)
Clinical Indication
Type 1 and 2 diabetes
Comments
Conditional on prescriber being competent to select appropriate patients
Date of classification
February 2019
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.